FUNGAL NAIL TREATMENT KIT- Cream-205
- Manufacturer
- GETHSEMANE BRANCH CORPORATION
- Effective date
- 2026-07-17
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- daily-update
- Hydrated at
- 2026-08-08 02:00:59
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
- Pseudolarix Amabilis Bark 1%
- Stemona Japonica Root 2%
- Coptis Chinensis Root 1%
- Sophora Flavescens Root 1.5%
- Atractylodes Lancea Root 1%
- Borneol 1.5%
- Camphor (Natural) 1%
- Propylene Glycol 1.5%
- Salicylic Acid 1%
OTC - PURPOSE SECTION
- Anti-Fungal
- Anti-Fungal
- Anti-Fungal
- Anti-Bacterial
- Anti-Bacterial
- Reduces itching
- Reduces itching
- Lubricating & Moisturizing
- Cleanse Skin Tissue
DOSAGE & ADMINISTRATION SECTION
Hinder fungal and bacterial growth, reduces itching, cleanse skin tissue.
WARNINGS SECTION
For external use only.
Do not use
- on irritated skin on any area that is infected or reddened
- Do not use it if pregnant or if there is any allergic reaction to this product
- Avoid contact with eyes.
Ask a doctor before you use
If you have diabetes or poor blood circulation
Stop use and ask a doctor
If discomfort persists
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
- If product gets into eyes, flush with water for 15 minutes
- If swallowed, get medical help or contact a Poison Control Center right away
INDICATIONS & USAGE SECTION
- Wash feet thoroughly with warm water, and gently file thickened par of the fungal nail with a nail file until it's flat
- Apply a layer of the liquid to the surface of the fungal nail and allow it to be absorbed into the nail
- After the liquid has been absorbed, apply a layer of the cream to the infected parts of the nail
- Repeat the process if necessary once a day.
INACTIVE INGREDIENT SECTION
White Petrolatum, Camphor Oil, White, Stearic Acid, Glyceryl Monostearate, Carbomer
OTC - QUESTIONS SECTION
NEWMIST LLC
EARTH CITY, MISSOURI 63045
www.inaturalvine.com
service@inaturalvine.com
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Products#
Every source-derived product name is available through these pages.
- FUNGAL NAIL TREATMENT kit .cream.
- Pseudolarix Amabilis Bark 1%
- STEARIC ACID
- STEMONA JAPONICA ROOT
- ATRACTYLODES LANCEA ROOT
- GLYCERYL MONOSTEARATE
- COPTIS CHINENSIS ROOT
- CAMPHOR (NATURAL)
- BORNEOL
- PROPYLENE GLYCOL
- SALICYLIC ACID
- WHITE PETROLATUM
- CARBOMER
- SOPHORA FLAVESCENS ROOT
- PSEUDOLARIX AMABILIS BARK
- CAMPHOR OIL, WHITE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 87870-002 | 87870-002-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| STEARIC ACID | 4ELV7Z65AP | IACT |
| STEMONA JAPONICA ROOT | FXG254HF10 | ACTIB |
| ATRACTYLODES LANCEA ROOT | CAZ6282J2O | ACTIB |
| GLYCERYL MONOSTEARATE | 230OU9XXE4 | IACT |
| COPTIS CHINENSIS ROOT | CXS4LJR7EL | ACTIB |
| CAMPHOR (NATURAL) | N20HL7Q941 | ACTIB |
| BORNEOL | M89NIB437X | ACTIB |
| PROPYLENE GLYCOL | 6DC9Q167V3 | ACTIB |
| SALICYLIC ACID | O414PZ4LPZ | ACTIB |
| WHITE PETROLATUM | B6E5W8RQJ4 | IACT |
| CARBOMER | 0A5MM307FC | IACT |
| SOPHORA FLAVESCENS ROOT | IYR6K8KQ5K | ACTIB |
| PSEUDOLARIX AMABILIS BARK | 49G13A93VE | ACTIB |
| CAMPHOR OIL, WHITE | 26P3H26Z9X | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| FUNGAL NAIL TREATMENT kit .cream. | PSEUDOLARIX AMABILIS BARK 1% | GETHSEMANE BRANCH CORPORATION | 56c9d9fa-09ad-e26a-e063-6394a90a0ed9 | 2026-07-17 | Warnings | 87870-002-01 87870-002 87870000201 56c9d9fa-09ae-e26a-e063-6394a90a0ed9 56c9d9fa-09ad-e26a-e063-6394a90a0ed9 |
| FUNGAL NAIL TREATMENT kit | PSEUDOLARIX AMABILIS BARK 1% | GETHSEMANE BRANCH CORPORATION | 56cb7085-87d8-4273-e063-6394a90ac5df | 2026-07-17 | Warnings | 87870-002-01 87870000201 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
